Rituximab vs Warfarin

## Rituximab vs Warfarin: Overview

This comparison examines the pharmacological differences between **Rituximab** and **Warfarin**.

## Mechanism of Action

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

**Warfarin**: Inhibits vitamin K epoxide reductase complex.

## Pharmacokinetics

**Half-life**: Rituximab — 22 days; Warfarin — 20-60 hours.

## Chemical Properties

**Molecular Formula**: Rituximab — N/A; Warfarin — C19H16O4.

**Molecular Weight**: Rituximab — N/A; Warfarin — 308.3280 g/mol.

**Type**: Rituximab — Antibody; Warfarin — Small molecule.